IQVIA raises 2026 outlook after record third-quarter bookingsOct 27Quarterly updateIqvia Holdings Inc.
AstraZeneca pediatric NEXIUM trial for erosive esophagitis listed as completedOct 13Trial updateAstraZenecaesomeprazole
CTX-471 trial terminated after combo arm misses efficacy; two device trials await startOct 9Weekly roundup, 3 itemsCompass TherapeuticsCTX-471
IQVIA raises 2026 guidance after strong second-quarter bookings and revenue growthJul 28Quarterly updateIqvia Holdings Inc.